fda bpc 157 warning compounding Targets GLP-1 and Peptide Compounding, Advertising and 'Research Use Only' Labeling π¨ CBP Chicago Intercepts 89
Description
Approximate doses per vial 40.0 doses Math reference only for in-vitro and laboratory research use
As a result, insurance companies often classify these therapies as elective or investigational, which places them outside the scope of standard insurance coverage
Not For Human Or Animal Consumption
A simple wellness shot with clear expectations
Feel the Difference One Injection Can Make Submit your free intake form todayno commitment required
